Neuland Laboratories Ltd Quarterly Results

Gross Sales

398.03

310.84

439.6

385.01

392.83

Excise Duty

0

0

0

0

0

Net Sales

398.03

310.84

439.6

385.01

392.83

Other Operating Income

0

0

0

0

0

Other Income

59.68

4.33

25.43

5.36

2.1

Total Income

457.72

315.18

465.03

390.37

394.93

Total Expenditure

311.43

248.62

316.24

278.09

271.56

PBIDT

146.28

66.56

148.79

112.27

123.37

Interest

2.22

1.06

2.67

3.61

3.74

PBDT

144.07

65.5

146.12

108.66

119.62

Depreciation

16.3

16.07

16.28

16.46

15.14

Minority Interest Before NP

0

0

0

0

0

Tax

24.95

12.21

30.58

21.99

25.29

Deferred Tax

1.23

4.37

1.39

2.65

-2.2

Reported Profit After Tax

101.59

32.84

97.87

67.56

81.39

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

101.59

32.84

97.87

67.56

81.39

Extra-ordinary Items

44.35

0

15.55

0

0

Adjusted Profit After Extra-ordinary item

57.24

32.84

82.32

67.56

81.39

EPS (Unit Curr.)

79.18

25.6

76.28

52.66

63.44

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.9

12.9

12.9

12.9

12.9

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

36.75

21.41

33.84

29.16

31.4

PBDTM(%)

36.19

21.07

33.23

28.22

30.45

PATM(%)

25.52

10.56

22.26

17.54

20.71